Back to User profile » Dr Megan E. Cavet

Papers published by Dr Megan E. Cavet:

Original Research

Loteprednol etabonate (submicron) ophthalmic gel 0.38% dosed three times daily following cataract surgery: integrated analysis of two Phase III clinical studies

Fong R, Cavet ME, DeCory HH, Vittitow JL

Clinical Ophthalmology 2019, 13:1427-1438

Published Date: 1 August 2019

Clinical Trial Report

Bepotastine besilate ophthalmic solution 1.5% for alleviating nasal symptoms in patients with allergic conjunctivitis

Cavet ME, Gomes PJ, Carr WW, Williams JI

Journal of Asthma and Allergy 2018, 11:29-39

Published Date: 23 March 2018

Original Research

Mapracorat, a selective glucocorticoid receptor agonist, causes apoptosis of eosinophils infiltrating the conjunctiva in late-phase experimental ocular allergy

Baiula M, Bedini A, Baldi J, Cavet ME, Govoni P, Spampinato S

Drug Design, Development and Therapy 2014, 8:745-757

Published Date: 10 June 2014